BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Regeneron Reports First Quarter 2022 Financial and Operating Results

  Regeneron Pharmaceuticals, Inc. announced financial results for the first quarter of 2022 and provided a business update.

  May 4, 2022

   · 

  24 min read
• Business

  Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results

  IVERIC bio, Inc. announced financial and operating results for the first quarter ended March 31, 2022 and provided a general business update.

  May 4, 2022

   · 

  14 min read
• Genetown

  Apnimed Announces $62.5 Million Series C Financing to Advance Development of Novel Pharmaceutical Treatments for Obstructive Sleep Apnea (OSA) and Related Sleep Disorders

  Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea and related disorders, announced that it has raised $62.5 million of committed capital in a Series C financing.

  May 4, 2022

   · 

  5 min read
• Business

  Editas Medicine Announces First Quarter 2022 Results and Business Updates

  Editas Medicine, Inc., a leading genome editing company, reported business highlights and financial results for the first quarter of 2022.

  May 4, 2022

   · 

  18 min read
• Pharm Country

  Merck to Participate in Bank of America Securities 2022 Healthcare Conference

  Merck, known as MSD outside the United States and Canada, announced that Executive Vice President and Chief Financial Officer Caroline Litchfield will participate in a fireside chat at the live Bank of America Securities 2022 Healthcare Conference.

  May 4, 2022

   · 

  3 min read
• Genetown

  Akouos to Present at Bank of America 2022 Healthcare Conference

  Akouos, Inc. announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer of Akouos, will participate in a presentation at the Bank of America 2022 Healthcare Conference on Tuesday, May 10 at 10:00 a.m. PDT in Las Vegas, Nevada.

  May 4, 2022

   · 

  1 min read
• Business

  Conformis Reports First Quarter 2022 Financial Results

  Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2022.

  May 4, 2022

   · 

  10 min read
• Pharm Country

  Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference

  Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2022 Healthcare Conference in Las Vegas, NV on Wednesday, May 11, 2022 at 12:00 p.m. P.T.

  May 4, 2022

   · 

  1 min read
• Drug Development

  Starton Therapeutics Provides Update on STAR-LLD Lenalidomide Clinical Program

  Starton Therapeutics Inc., a clinical stage biotechnology company provides updates on its first-in-human Phase 1 STAR-LLD clinical trial of its investigational continuous delivery lenalidomide, in healthy subjects.

  May 4, 2022

   · 

  4 min read
• Business

  Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results

  Horizon Therapeutics plc (Nasdaq: HZNP) today announced first-quarter 2022 financial results and maintained its full-year 2022 net sales and adjusted EBITDA guidance.

  May 4, 2022

   · 

  36 min read